Skip to main content

Table 2 Study assessments and timetable

From: A crossover randomized comparative study of zofenopril and ramipril on cough reflex and airway inflammation in healthy volunteers

 

1st treatment period

Wash-out

2nd treatment period

Day(s)

1

2

3

4

5

6

7

8-29(±2)

30

31

32

33

34

35

36

Drug dosing

x

x

x

x

x

x

x

 

x

x

x

x

x

x

x

Vital signs recordings

x

     

x

 

x

     

x

Capsaicin and citric acid challenges

x

     

x

 

x

     

x

Spontaneous cough recordings at home

From day 1 to 7

 

From day 30 to 36

FeNO measurementa

x

     

x

 

x

     

x

Assessment of pre-dose PK parameters

x

 

x

 

x

x

x

 

x

 

x

 

x

x

x

Assessment of post-dose PK parametersb

      

x

       

x

Pre-dose BK measurements

x

     

x

 

x

     

x

Post-dose BK measurementsc

      

x

       

x

AE monitoring

From day 1 to 7

  

From day 30 to 36

  1. FeNO, fractional exhaled nitric oxide; AE, adverse event; PK, pharmacokinetic; BK, bradykinin; a FeNO assessments were performed at pre-dose, 1.5 h and 5.5 h post-dose; bBlood samples obtained 20', 40', 1 h, 1 h30', 2 h, 3 h, 4 h, 5 h, 6 h, 8 h, 10 h, 12 h, 16 h, 24 h after drug administration; c measurement performed 40', 1 h, 2 h, 4 h, 6 h, 10 h, 16 h, and 24 h after drug administration.